Home
Finance & valuation

Finance & valuation

South Korea’s IP-backed lending market growth exceeds targets

Although heavy reliance on government-backed initiatives creates uncertain future for IP holders

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

JS Held expands Ocean Tomo IP practice with new acquisition

The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff

Latest content

Portfolio analysis shows BlackBerry’s new director of licensing has a lot to work with

The Canadian tech giant’s patents pack a punch and claims of a technologically diverse holding ring true, but slowing filing levels leave pipeline questions

11 September 2020

New licensing entity picks up portfolios from Samsung, Kyocera and TCL

Japan-based LLC’s first monetisation move is a licensor spot in Via’s LTE pool

11 September 2020

Pharma patent deal-making may be back with a bang

Following a spate of licensing deals, high-value life sciences M&A now seems to be back in business after a pandemic-induced pause

10 September 2020

The top 10 takeaways from this year’s Global Innovation Index

The latest edition of the annual WIPO publication reveals that Europe and North America still lead despite rising innovation levels in Asia

09 September 2020

Geely to boost R&D war chest with Shanghai listing

China’s next big IPO will feature one of the country’s auto IP leaders, which has more than 9,000 patents and counts licensing as a major revenue source

07 September 2020

Sanofi eyes more M&A as deals drive increase in IP portfolio quality

The French pharmaceutical’s holdings have shrunk over recent years and application output is at a low, but recent acquisitions have provided a boost while a patent revamp is around the corner

28 August 2020

Translational research key to realising value of university IP, says UCL biopharma chief

Dr Richard Fagan of University College London Business tells IAM about the process of turning patents for early-stage research into investable assets

27 August 2020